JP2017165772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017165772A5 JP2017165772A5 JP2017111807A JP2017111807A JP2017165772A5 JP 2017165772 A5 JP2017165772 A5 JP 2017165772A5 JP 2017111807 A JP2017111807 A JP 2017111807A JP 2017111807 A JP2017111807 A JP 2017111807A JP 2017165772 A5 JP2017165772 A5 JP 2017165772A5
- Authority
- JP
- Japan
- Prior art keywords
- revascularization
- use according
- subject
- hours
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000250 revascularization Effects 0.000 claims 18
- 239000003814 drug Substances 0.000 claims 4
- 239000003527 fibrinolytic agent Substances 0.000 claims 2
- 230000009257 reactivity Effects 0.000 claims 2
- 230000008327 renal blood flow Effects 0.000 claims 2
- 229960000103 thrombolytic agent Drugs 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- 102000013566 Plasminogen Human genes 0.000 claims 1
- 108010051456 Plasminogen Proteins 0.000 claims 1
- 206010048988 Renal artery occlusion Diseases 0.000 claims 1
- 208000027032 Renal vascular disease Diseases 0.000 claims 1
- 108010023197 Streptokinase Proteins 0.000 claims 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 1
- 238000002399 angioplasty Methods 0.000 claims 1
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 230000024924 glomerular filtration Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940012957 plasmin Drugs 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 208000015670 renal artery disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 108010073863 saruplase Proteins 0.000 claims 1
- 229960005202 streptokinase Drugs 0.000 claims 1
- 108010008962 streptokinase-plasminogen complex Proteins 0.000 claims 1
- 229960000187 tissue plasminogen activator Drugs 0.000 claims 1
- 229960005356 urokinase Drugs 0.000 claims 1
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161540910P | 2011-09-29 | 2011-09-29 | |
| US61/540,910 | 2011-09-29 | ||
| US201161558177P | 2011-11-10 | 2011-11-10 | |
| US61/558,177 | 2011-11-10 | ||
| US201261596455P | 2012-02-08 | 2012-02-08 | |
| US61/596,455 | 2012-02-08 | ||
| US201261642282P | 2012-05-03 | 2012-05-03 | |
| US61/642,282 | 2012-05-03 | ||
| US201261681444P | 2012-08-09 | 2012-08-09 | |
| US61/681,444 | 2012-08-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533434A Division JP6157481B2 (ja) | 2011-09-29 | 2012-09-28 | 芳香族陽イオン性ペプチドおよびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017165772A JP2017165772A (ja) | 2017-09-21 |
| JP2017165772A5 true JP2017165772A5 (cg-RX-API-DMAC7.html) | 2018-05-10 |
| JP6465927B2 JP6465927B2 (ja) | 2019-02-06 |
Family
ID=47996475
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533434A Active JP6157481B2 (ja) | 2011-09-29 | 2012-09-28 | 芳香族陽イオン性ペプチドおよびその使用方法 |
| JP2017111807A Active JP6465927B2 (ja) | 2011-09-29 | 2017-06-06 | 芳香族陽イオン性ペプチドおよびその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533434A Active JP6157481B2 (ja) | 2011-09-29 | 2012-09-28 | 芳香族陽イオン性ペプチドおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9988422B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2760460B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6157481B2 (cg-RX-API-DMAC7.html) |
| CN (3) | CN107496899A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2012315586B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3123992C (cg-RX-API-DMAC7.html) |
| HK (1) | HK1249406A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013049697A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496899A (zh) * | 2011-09-29 | 2017-12-22 | 梅约医学教育与研究基金会 | 芳族阳离子肽和使用它们的方法 |
| CA2858550A1 (en) * | 2011-12-09 | 2013-06-13 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| EP3626252A1 (en) | 2013-03-01 | 2020-03-25 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention or treatment of barth syndrome |
| US10793597B2 (en) | 2013-03-01 | 2020-10-06 | Stealth Biotherapeutics Corp | Methods for the treatment of mitochondrial diseases associated with a mutation in SURF 1 or POLG gene resulting in a disruption of mitochondrial oxidative phosphorylation |
| EP3586864A1 (en) * | 2013-05-14 | 2020-01-01 | Stealth Biotherapeutics Corp | Methods for the prevention or treatment of left ventricle remodeling |
| US10047395B2 (en) | 2013-06-26 | 2018-08-14 | Stealth Biotherapeutics Corp | Methods and compositions for detecting and diagnosing diseases and conditions |
| CA2916492A1 (en) | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
| CA2920020C (en) * | 2013-08-02 | 2023-03-14 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention and treatment of friedreich's ataxia |
| WO2016004067A1 (en) * | 2014-06-30 | 2016-01-07 | Stealth Biotherapeutics Corp | Aromatic-cationic peptide formulations, compositions and methods of use |
| CA3008466C (en) | 2015-12-18 | 2023-06-20 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
| CA3010321A1 (en) * | 2015-12-31 | 2017-07-06 | Scott Duncan | Therapeutic compositions including peptides and uses thereof |
| US10870678B2 (en) | 2016-04-11 | 2020-12-22 | Arcuate Therapeutics, Inc. | Chiral peptides |
| CA3047170A1 (en) * | 2016-12-15 | 2018-06-21 | Talengen International Limited | Method for preventing and treating drug-induced renal injury |
| US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
| IL305687B2 (en) * | 2017-12-15 | 2024-12-01 | Stealth Biotherapeutics Inc | Mitochondria-targeting peptides |
| US11795196B2 (en) | 2017-12-15 | 2023-10-24 | Stealth Biotherapeutics Inc. | Mitochondria-targeting peptides |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| FR3079142B1 (fr) * | 2018-03-23 | 2020-11-27 | Matieres Premieres Int | Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables |
| US12002199B2 (en) * | 2018-09-28 | 2024-06-04 | The Board Of Regents Of The University Of Texas System | Methods, apparatuses, and systems for 3-D phenotyping and physiological characterization of brain lesions and surrounding tissue |
| CN117881411A (zh) | 2021-06-01 | 2024-04-12 | 艾迪雅生物有限责任公司 | 用于眼部药物的延长释放药物递送系统和使用方法 |
| JP2024521373A (ja) * | 2021-06-01 | 2024-05-31 | アイディア バイオ，エルエルシー | 硝子体内ミトコンドリア標的化ペプチドプロドラッグおよび使用方法 |
| CN113718029A (zh) * | 2021-10-22 | 2021-11-30 | 中国人民解放军北部战区总医院 | S100a4蛋白在动脉粥样硬化性肾动脉狭窄诊断中的应用 |
| EP4230196A1 (en) | 2022-02-21 | 2023-08-23 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of dystrophinopathies |
| EP4491132A4 (en) * | 2022-03-31 | 2025-06-18 | Terumo Kabushiki Kaisha | PROGRAM, INFORMATION PROCESSING METHOD AND INFORMATION PROCESSING DEVICE |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| DK72587D0 (da) | 1987-02-13 | 1987-02-13 | Carlsberg Biotechnology Ltd | Fremgangsmaade til enzymatisk fremstilling af dipeptider |
| SG64368A1 (en) | 1988-06-30 | 1999-04-27 | Astra Ab | Dermorphin analogs their methods of preparation pharmaceutical compositions and methods of therapeutic treatment using the same |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5573957A (en) * | 1994-09-28 | 1996-11-12 | Spectral Diagnostics, Inc. | Monoclonal antibody to human cardiac myoglobin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| FR2771010B1 (fr) * | 1997-11-19 | 2003-08-15 | Adir | Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| WO2000044365A1 (en) | 1999-01-29 | 2000-08-03 | Millennium Pharmaceuticals, Inc. | Methods for preventing graft rejection and ischemia-reperfusion injury |
| CN101440124B (zh) * | 2003-02-04 | 2012-07-18 | 科内尔研究基金会 | 用于防止线粒体通透性改变的方法 |
| SI2656854T1 (sl) | 2003-02-04 | 2015-09-30 | Cornell Research Foundation, Inc. | Uporabe aromatsko-kationskega peptida |
| EP3167935B1 (en) | 2003-05-01 | 2018-07-18 | Cornell Research Foundation, Inc. | Method and carrier complexes for delivering molecules to cells |
| US10517883B2 (en) * | 2003-06-27 | 2019-12-31 | Zuli Holdings Ltd. | Method of treating acute myocardial infarction |
| US20060051407A1 (en) | 2003-06-27 | 2006-03-09 | Yoram Richter | Method of treating ischemia-reperfusion injury |
| CA3024434A1 (en) * | 2004-01-23 | 2005-08-11 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| CA2562957C (en) | 2004-03-31 | 2013-05-21 | The Feinstein Institute For Medical Research | Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| CA2655144A1 (en) * | 2006-06-15 | 2007-12-21 | Gilead Colorado, Inc. | Antihypertensive therapy method |
| US20100305183A1 (en) * | 2006-12-08 | 2010-12-02 | Adelaide Research & Innovation Pty Ltd | Method and composition for reducing reperfusion injury |
| EP2120782B1 (en) | 2007-01-03 | 2018-10-10 | Boston Scientific Scimed, Inc. | Pelvic implant |
| AU2008306264A1 (en) | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents |
| JP2010538991A (ja) | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | 治療剤としてのｓｆｌｌｒ−ｏｈおよびムラミルジペプチドの使用 |
| CN107802821A (zh) | 2008-02-26 | 2018-03-16 | 康奈尔大学 | 用于防止和治疗急性肾损伤的方法 |
| GB0805912D0 (en) | 2008-04-01 | 2008-05-07 | Bioalvo Servi Os Investiga Oo | Treatment |
| GB0805862D0 (en) | 2008-04-01 | 2008-04-30 | Bioalvo Servi Os Investiga Oo | Method |
| EP3563862B1 (en) | 2009-03-20 | 2021-05-05 | The General Hospital Corporation d/b/a Massachusetts General Hospital | D-arg-2'6'-dimethyltyrosine-lys-phe-nh2 for use in the prevention of secondary complications of burn injuries |
| EP2311554A1 (en) | 2009-10-07 | 2011-04-20 | Linde Aktiengesellschaft | Method for reaction control of exothermic reaction and apparatus therefore |
| EP2519249A4 (en) * | 2009-12-31 | 2013-06-26 | Stealth Peptides Int Inc | METHOD FOR CARRYING OUT A CORONARY ARTERY BYPASS PROCEDURE |
| US20130195837A1 (en) * | 2009-12-31 | 2013-08-01 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
| CA2787331A1 (en) | 2010-01-25 | 2011-07-28 | Hazel H. Szeto | Aromatic-cationic peptides and uses of same |
| EP2808029A3 (en) * | 2010-03-15 | 2015-04-01 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
| CN107496899A (zh) * | 2011-09-29 | 2017-12-22 | 梅约医学教育与研究基金会 | 芳族阳离子肽和使用它们的方法 |
| CA2858550A1 (en) | 2011-12-09 | 2013-06-13 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| US20150119552A1 (en) | 2012-04-12 | 2015-04-30 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
-
2012
- 2012-09-28 CN CN201710610548.1A patent/CN107496899A/zh active Pending
- 2012-09-28 CN CN201280058908.7A patent/CN103987397A/zh active Pending
- 2012-09-28 CN CN201610917018.7A patent/CN106913860A/zh active Pending
- 2012-09-28 CA CA3123992A patent/CA3123992C/en active Active
- 2012-09-28 AU AU2012315586A patent/AU2012315586B2/en active Active
- 2012-09-28 EP EP12835846.2A patent/EP2760460B1/en active Active
- 2012-09-28 JP JP2014533434A patent/JP6157481B2/ja active Active
- 2012-09-28 WO PCT/US2012/058091 patent/WO2013049697A1/en not_active Ceased
- 2012-09-28 CA CA2850520A patent/CA2850520C/en active Active
- 2012-09-28 US US14/347,998 patent/US9988422B2/en active Active
-
2017
- 2017-06-06 JP JP2017111807A patent/JP6465927B2/ja active Active
- 2017-10-18 AU AU2017248477A patent/AU2017248477B2/en active Active
- 2017-12-13 US US15/840,700 patent/US20180327450A1/en not_active Abandoned
-
2018
- 2018-06-22 HK HK18108024.3A patent/HK1249406A1/zh unknown
- 2018-10-24 AU AU2018253546A patent/AU2018253546A1/en not_active Abandoned
-
2019
- 2019-12-20 US US16/724,037 patent/US11420998B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016172781A5 (cg-RX-API-DMAC7.html) | ||
| Kim | Management of acute variceal bleeding | |
| Stefanini et al. | Management of Myocardial Revascularization Failure: An Expert Consensus | |
| JP2013516425A5 (cg-RX-API-DMAC7.html) | ||
| JP2020506907A (ja) | 血栓塞栓症の治療方法 | |
| Stock et al. | Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator | |
| Ogawa et al. | Antithrombotic Therapy in Atrial Fibrillation–Evaluation and Positioning of New Oral Anticoagulant Agents– | |
| Jolly et al. | Pulmonary embolism: current role of catheter treatment options and operative thrombectomy | |
| Al-Hijji et al. | Revascularization for left main and multivessel coronary artery disease: current status and future prospects after the EXCEL and NOBLE Trials | |
| Blum et al. | Endovascular management of acute deep vein thrombosis | |
| Wheatley et al. | The use of intra-arterial urokinase in the management of hand ischemia secondary to palmar and digital arterial occlusion | |
| Dmytriw et al. | Mechanical thrombectomy and the future of acute stroke treatment | |
| KR20190072011A (ko) | 나토키나제와 항염증제를 유효성분으로 포함하는 혈소판 응집 억제용 또는 혈전용해용 의약 조성물 | |
| Lim et al. | Spontaneous renal artery thrombosis: a rare cause of acute flank pain | |
| CN108815171A (zh) | 25-羟基胆固醇在制备治疗或预防心肌梗死的药物中的应用 | |
| Jung et al. | Successful surgical treatment of a right atrial myxoma complicated by pulmonary embolism | |
| Palaia | Idiopathic fibrous hyperplasia of the palate | |
| BLUM | Successful removal of a tumor embolus from the femoral artery | |
| RU2617108C1 (ru) | Способ первичносклерозирующего профилактического гемостаза на высоте кровотечения из варикозных вен пищевода и желудка | |
| Nair et al. | Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention | |
| Goldhaber | Management of deep venous thrombosis and pulmonary embolism | |
| US20220265291A9 (en) | Pharmaceutical compositions and methods for the treatment of thrombosis and delivery by medical devices | |
| Mistry et al. | Vascular Access Guidelines | |
| Banerjee et al. | Effect of preimplant endovascular debulking strategies on the deployment of nitinol self-expanding stents in superficial femoral arteries | |
| Leboutte et al. | Percutaneous Management of Septic Left Anterior Descending Coronary Occlusion Following Minimally Invasive Surgery for Mitral Valve Infective Endocarditis |